JATT III ACQUISITION CORP
Searching since IPO 2026-08-26- CIK 2145659
- JTTT
- IPO 2026-08-26
- $69.2M trust
- 21 filings
- IPO Size
- $69M
- raised at the IPO
- Trust
- $69.2M
- as of 2026-09-30
- Current Status
- IPO
- from its latest filing
- IPO Year
- 2026
- year it listed
Filings, by quarter
21 filings over 2 quarters; violet bars carry a milestone
- 26 Q3: 20 filings
- 26 Q4: 1 filing
- S-1 filed 26 Q3
- IPO 26 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
JATT III Acquisition Corp. is a blank-check company seeking an unidentified initial business combination. It intends to focus on healthcare and healthcare-related businesses, particularly biotechnology and broader life sciences, including businesses using data-driven approaches to improve therapeutic discovery and development.
Investment Focus
Healthcare, Biopharmaceuticals
Key Information
As the filings state it
- IPO Date
- 2026-08-26
- Jurisdiction of Incorporation
- Cayman Islands
- SIC
- 6770
- SPAC Ticker
- JTTT
Stock Performance
JTTTTrading symbol, and its price at each step since the first trade
| Point | Date | Price | Move |
|---|---|---|---|
| First Trade | 2026-08-26 | $11.00 | |
| Current Price | 2026-11-13 | $10.23 | -7% |
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
Led by Chairman and CEO Someit Sidhu, a life-sciences entrepreneur and investor with prior SPAC and biotech leadership experience, and CFO Nicholas Fernandez, with over 20 years in finance and operations. The director nominees bring investment-banking and healthcare, biotechnology and life-sciences investing experience.